|
|
|
|
|
|
13.01.21 - 20:27
|
Regeneron Pharmaceuticals: Upgrade (Aktiencheck)
|
|
New York (www.aktiencheck.de) - Rating-Update:
Aydin Huseynov, Analyst von Benchmark Company, stuft die Aktie des Biotechkonzerns Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535, Ticker-Symbol: RGO, NASDAQ-Symbol: REGN) von "hold" au...
|
|
|
13.01.21 - 19:06
|
Why Regeneron, Jaguar Health And Seneca Are Moving Today (Benzinga)
|
|
Regeneron Pharmaceuticals (NASDAQ: REGN) shares are trading higher after the company announced an additional U.S. order to purchase 1.25 million doses of its COVID-19 antibody cocktail bringing the total number to over 1.5 million doses.
read more...
|
|
|
|
|
|
|
|
|
|
|
|
|
|